Treatment briefing

Esketamine and Ketamine for Depression

Esketamine (Spravato) is an approved nasal spray for treatment-resistant depression, with a strict protocol that makes funding decisions straightforward to test. Subcutaneous ketamine is a different, off-label treatment with a much weaker evidence base. This lesson teaches learners to tell them apart and to check a request against the protocol.